Clinical Trials Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Mar 7, 2019; 25(9): 1116-1131
Published online Mar 7, 2019. doi: 10.3748/wjg.v25.i9.1116
Figure 1
Figure 1 Flowchart of the study selection procedure.
Figure 2
Figure 2 Relative changes in fat components (A) and adipokines (B). A: Relative changes (boxplots) in body fat mass and lean body mass after the 24-wk intervention estimated by the BodPod device. Relative changes in intraabdominal fat, internal and subcutaneous abdominal fat measured by MRI. Significant differences from baseline are marked with for aP < 0.05 and bP < 0.01. B: Relative changes in adipokines (boxplot). Significant changes from baseline are marked with aP < 0.05.
Figure 3
Figure 3 Relative changes in hepatic lipid characteristics. Relative changes in hepatic lipid characteristics (boxplot). Significant changes from baseline are marked with aP < 0.05 or bP < 0.01.
Figure 4
Figure 4 Change in intrahepatic lipid in relation to weight loss. The relationship between change in body weight and change in intrahepatic lipid content. IHL: Intrahepatic lipid component.